Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2016-04-25 | New | $375,000 | $375,000 | Equity and Debt | 06b | SEC link |
| 2015-02-09 | New | $700,000 | $700,000 | Debt Only | 06b | SEC link |
| 2013-12-04 | New | $595,000 | $595,000 | Other | 06b | SEC link |
| 2010-05-10 | New | $1,925,000 | $1,925,000 | Equity Only | 06 | SEC link |
| 2007-01-03 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Richard Burgess | Director |
| Anthony Clemento | Director |
| Paul T. Evans | Director |
| Gary Greenwood | Director, Executive |
| Robert Lippert | Director, Executive |
| Alicia Loffler | Director |
| Brian Mc Loughlin | Director |
| Gary Noskin | Director |
| Carl Spalding | Director |
| H. Thomas Watkins | Director |
| H. Thomas Watkins | Director |
| Steven R. Watt | Executive |